The move highlights India’s growing role as a global hub for healthcare innovation and patient-focused medical infrastructure.

Novo Holdings, which manages assets for the Novo Nordisk Foundation, is strategically expanding its portfolio across India to tap into high-growth healthcare opportunities.

With India emerging as one of the fastest-growing healthcare markets globally, the company aims to support hospitals and pharmaceutical manufacturers that deliver specialized, high-quality care to millions of patients.

The company has significantly increased its investment size, now ranging between $50 million and $125 million per project, compared to earlier deals averaging $20 million to $30 million.

Novo Holdings has also set up a dedicated investment team in Mumbai, reinforcing its long-term commitment to the Indian healthcare sector and its mission to improve access to advanced medical care.

According to company leaders, single-specialty hospitals are becoming the cornerstone of modern healthcare delivery in India. These specialized hospitals, focusing on areas such as oncology, maternity and child care, nephrology, and cardiology, offer patients more personalized and efficient treatments.

As demand grows for focused medical expertise, Novo Holdings plans to invest heavily in this segment, which is expected to reach $40 billion by 2032, according to industry research.

In addition to hospital investments, Novo Holdings is exploring partnerships with contract drug manufacturers in India. These companies play a crucial role in producing complex biological medicines used in the treatment of chronic illnesses such as cancer, diabetes, and autoimmune disorders.

By supporting these pharmaceutical innovators, Novo aims to strengthen India’s position as a leading hub for affordable and high-quality drug production.

The company is also looking into long-term investments in India’s emerging medical technology sector. With increasing innovation in diagnostics, digital health, and patient monitoring, medtech offers immense potential to revolutionize healthcare accessibility and efficiency.

Novo Holdings believes that India’s growing startup ecosystem and skilled talent pool make it an ideal location for future-focused healthcare investment.

Another area of focus is senior care and post-surgery recovery services, often referred to as step-down care. As India’s aging population grows and the demand for long-term patient support increases, these services will become vital to easing the pressure on large hospitals while ensuring continued recovery for patients outside intensive care units.

Experts view Novo Holdings’ strategy as a strong vote of confidence in India’s healthcare transformation. With an increasing focus on innovation, quality, and patient outcomes, India has become an attractive destination for global healthcare investors.

Novo’s investment will likely accelerate improvements in infrastructure, create more skilled healthcare jobs, and enhance medical access across urban and rural regions alike.

The company’s approach reflects a broader global trend of investing in sustainable and patient-centric healthcare systems. By combining financial strength with deep industry expertise, Novo Holdings aims to help India shape the future of healthcare — one that is specialized, accessible, and innovation-driven.

Now in its eighth edition, the event has become a cornerstone for the Kingdom’s efforts to attract investment, foster innovation, and advance the strategic goals of Vision 2030.

The exhibition, held with the support of the Ministry of Health, will highlight Saudi Arabia’s commitment to enhancing healthcare quality, boosting the sector’s contribution to the economy, and establishing the Kingdom as a global hub for healthcare innovation and manufacturing.

Over the next decade, the Saudi healthcare industry is projected to grow significantly, from SR199 billion ($53 billion) in 2020 to SR318 billion by 2030, with private sector contributions expected to double to SR145 billion.

The Ministry of Health has emphasized its focus on creating a competitive investment environment, streamlining regulatory processes, and supporting innovation across critical areas such as biotechnology, pharmaceuticals, vaccine production, health tourism, digital health solutions, and artificial intelligence in healthcare.

These initiatives are designed to accelerate progress toward a self-sufficient, innovation-driven healthcare ecosystem in the Kingdom.

The Global Health Exhibition serves as a vital platform for connecting local and international stakeholders, showcasing the latest medical technologies, and facilitating high-value collaborations.

Last year’s edition generated investments exceeding SR50 billion, including key deals such as the SR4 billion pharmaceutical partnership between NUPCO, Novo Nordisk, and Sanofi, the SR5 billion expansion plan by Fakeeh Care Group, and acquisitions worth over SR4 billion by Dallah Healthcare.

Building on this momentum, the 2025 exhibition is expected to announce new agreements and collaborations in biotechnology, advanced medical technologies, AI-driven healthcare solutions, and digital health platforms.

These developments are expected to further strengthen Saudi Arabia’s position as a regional leader in medical innovation, research, and development, attracting global expertise and investment to the Kingdom.

Experts highlight that the exhibition not only provides a showcase for cutting-edge technology and services but also demonstrates the Kingdom’s commitment to Vision 2030 goals of improving healthcare outcomes, supporting economic diversification, and encouraging private sector growth.

By fostering partnerships in pharmaceuticals, biotech, and healthcare technologies, Saudi Arabia aims to reduce dependency on imports, enhance local manufacturing capabilities, and stimulate job creation in high-value sectors.

The Ministry of Health has also emphasized the role of the exhibition in promoting sustainable growth and innovation, particularly in fields like vaccine production, biotechnology research, digital health solutions, and AI-enabled healthcare tools.

These areas are expected to be central to the Kingdom’s long-term strategy of establishing a world-class healthcare ecosystem that combines technological innovation with high-quality patient care.

Stakeholders anticipate that the event will attract international investors, leading global healthcare companies, and innovative startups, creating opportunities for knowledge exchange, joint ventures, and technology transfer.

The exhibition is expected to highlight Saudi Arabia’s readiness to lead in medical research, biotechnology, and advanced healthcare solutions, reinforcing its role as a hub for global healthcare innovation.

As the Kingdom continues to implement initiatives aligned with Vision 2030, the Global Health Exhibition 2025 represents a critical platform for showcasing achievements, facilitating investment, and strengthening partnerships across the healthcare sector.

By leveraging new technologies, fostering collaboration, and expanding strategic partnerships, Saudi Arabia is well-positioned to enhance healthcare access, improve quality, and secure long-term sustainable growth.

In summary, the upcoming exhibition is set to be a landmark event for Saudi Arabia’s healthcare sector, underlining the Kingdom’s dedication to innovation, investment, and international collaboration.

The announcements and partnerships expected at the event will pave the way for a robust, self-sufficient, and technologically advanced healthcare ecosystem, reflecting Saudi Arabia’s ambition to lead in global healthcare innovation.